about
Management and outcomes for patients with TTP: analysis of 100 cases at a single institution.Over-testing for heparin induced thrombocytopenia in hospitalized patients.Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer.Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.Acral gangrene as a presentation of non-uremic calciphylaxis.Novel agents in the management of castration resistant prostate cancer.Recent advances in the antiphospholipid antibody syndrome.Blind men and the refractory ITP elephant.Diagnosis and management of the antiphospholipid syndrome.Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia.Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: A retrospective-prospective cohort studyDecreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysisOutcomes of Cardiovascular Surgery Utilizing Heparin versus Direct Thrombin Inhibitors in Cardiopulmonary Bypass in Patients with Previously Diagnosed HITReduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivorsHow targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknownsPreoperative treatment of anemia and outcomes in surgical Jehovah's Witness patients
P50
Q33407187-6DB8A0E5-43B3-4D33-9B68-3035F960F3BBQ33417093-2C68ACEE-1D2F-4EEC-AEFB-FBA49944F3BFQ34050284-4831AC3C-2C66-4559-BDF0-C43ACF8EB51DQ34749444-27116B4C-AA55-48E6-8C0E-7551901E81F3Q37345240-70D155F6-6046-4E02-ABD7-3289A159F42BQ38209656-EA2FE792-D1A2-4240-97DB-91522C41556AQ38229433-A8A0D477-59DE-4432-9B36-0F5E8B044958Q38694136-6776033D-3D95-4B9E-9D56-B56C00A475FCQ47982275-940DCC2A-200C-4500-8BB6-B3D6EB12CFDAQ48325474-0A6939DC-F92C-4024-80A2-9A67AC86AE08Q89452402-8C3F7AF4-5BA6-490E-BCA2-8FD09BF5A737Q90365516-EB059DD3-83A3-4991-95CD-98CCCE26A327Q92324788-8FEC4A0C-79CC-4822-ADEC-77212543BC3FQ92733885-01705F24-65E3-4332-845E-5AB919582C27Q92882987-BAEC3FFC-21AA-49F7-A181-9746BD0C4445Q93357393-E09283B0-FEB8-4818-BB56-6C6A5A3AA646
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6832-2389
@en
name
Shruti Chaturvedi
@ast
Shruti Chaturvedi
@en
Shruti Chaturvedi
@es
Shruti Chaturvedi
@nl
type
label
Shruti Chaturvedi
@ast
Shruti Chaturvedi
@en
Shruti Chaturvedi
@es
Shruti Chaturvedi
@nl
prefLabel
Shruti Chaturvedi
@ast
Shruti Chaturvedi
@en
Shruti Chaturvedi
@es
Shruti Chaturvedi
@nl
P106
P31
P496
0000-0001-6832-2389